Maria Charlotte Fribert
Algemeen Directeur bij TOLERANZIA AB
Profiel
Maria Charlotte Fribert is the founder of Epixis SA. She is currently the Chief Executive Officer at Toleranzia AB since 2016.
Previously, she worked at AstraZeneca R&D Mölndal as a Project Director-Drug Development.
Dr. Fribert holds a doctorate degree from Université Pierre et Marie Curie.
Actieve functies van Maria Charlotte Fribert
| Bedrijven | Functie | Begin |
|---|---|---|
| TOLERANZIA AB | Algemeen Directeur | 11-04-2016 |
Eerdere bekende functies van Maria Charlotte Fribert
| Bedrijven | Functie | Einde |
|---|---|---|
Epixis SA
 Epixis SA BiotechnologyHealth Technology Epixis SA is a biotechnology company that develops platform for preventive and therapeutic vaccines based on VLPs ('virus-like particles'). It manufactures seasonal or pandemic flu vaccines, to treat Hepatitis C, and to be applied to other infectious diseases, such as Human papillomavirus (HPV) or Human immunodeficiency virus (HIV). The company was incorporated in 2003 and is headquartered in Paris, Frace. | Oprichter | - |
| AstraZeneca R&D Mölndal | Corporate Officer/Principal | - |
Opleiding van Maria Charlotte Fribert
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TOLERANZIA AB | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
| Université Pierre et Marie Curie | Consumer Services |
| AstraZeneca R&D Mölndal | |
Epixis SA
Epixis SA BiotechnologyHealth Technology Epixis SA is a biotechnology company that develops platform for preventive and therapeutic vaccines based on VLPs ('virus-like particles'). It manufactures seasonal or pandemic flu vaccines, to treat Hepatitis C, and to be applied to other infectious diseases, such as Human papillomavirus (HPV) or Human immunodeficiency virus (HIV). The company was incorporated in 2003 and is headquartered in Paris, Frace. | Health Technology |
